CH646604A5 - Composition pharmaceutique a effet prolonge et son procede de fabrication. - Google Patents

Composition pharmaceutique a effet prolonge et son procede de fabrication. Download PDF

Info

Publication number
CH646604A5
CH646604A5 CH9281A CH9281A CH646604A5 CH 646604 A5 CH646604 A5 CH 646604A5 CH 9281 A CH9281 A CH 9281A CH 9281 A CH9281 A CH 9281A CH 646604 A5 CH646604 A5 CH 646604A5
Authority
CH
Switzerland
Prior art keywords
agent
release
composition according
tablets
amount
Prior art date
Application number
CH9281A
Other languages
English (en)
French (fr)
Inventor
James Michael Dunn
John Francis Lampard
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of CH646604A5 publication Critical patent/CH646604A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH9281A 1980-01-11 1981-01-08 Composition pharmaceutique a effet prolonge et son procede de fabrication. CH646604A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments

Publications (1)

Publication Number Publication Date
CH646604A5 true CH646604A5 (fr) 1984-12-14

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
CH9281A CH646604A5 (fr) 1980-01-11 1981-01-08 Composition pharmaceutique a effet prolonge et son procede de fabrication.

Country Status (22)

Country Link
JP (1) JPS56103110A (et)
AT (1) AT374681B (et)
AU (1) AU542824B2 (et)
BE (1) BE886998A (et)
CA (1) CA1140466A (et)
CH (1) CH646604A5 (et)
DE (1) DE3100191A1 (et)
DK (1) DK6181A (et)
ES (2) ES8205353A1 (et)
FI (1) FI76927C (et)
FR (1) FR2473308B1 (et)
GB (1) GB2067072B (et)
GR (1) GR73843B (et)
IE (1) IE50806B1 (et)
IN (1) IN151913B (et)
IT (1) IT1221041B (et)
LU (1) LU83052A1 (et)
NL (1) NL8100037A (et)
NO (1) NO156153C (et)
NZ (1) NZ195933A (et)
SE (1) SE447450B (et)
ZA (1) ZA81136B (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
DE3486029T2 (de) * 1983-10-14 1993-05-13 Sumitomo Pharma Ifn-praeparat mit verzoegerter abgabe fuer parentale verabreichung.
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
CA1277601C (en) * 1985-12-27 1990-12-11 Shigeji Sato Method for producing sustained release formulation
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5855915A (en) * 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL265428A (et) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
AT374681B (de) 1984-05-25
LU83052A1 (fr) 1982-09-10
ES509179A0 (es) 1982-12-16
DE3100191A1 (de) 1981-12-10
JPS56103110A (en) 1981-08-18
GR73843B (et) 1984-05-07
IT8147537A0 (it) 1981-01-09
FI76927B (fi) 1988-09-30
ES498369A0 (es) 1982-06-01
SE8100104L (sv) 1981-07-12
ZA81136B (en) 1982-01-27
DK6181A (da) 1981-07-12
IT1221041B (it) 1990-06-21
AU542824B2 (en) 1985-03-14
ATA5481A (de) 1983-10-15
IE810036L (en) 1981-07-11
ES8301629A1 (es) 1982-12-16
NZ195933A (en) 1982-11-23
FR2473308B1 (fr) 1985-07-19
GB2067072B (en) 1983-08-10
IE50806B1 (en) 1986-07-23
NO810062L (no) 1981-07-13
CA1140466A (en) 1983-02-01
FR2473308A1 (fr) 1981-07-17
NO156153B (no) 1987-04-27
BE886998A (fr) 1981-07-08
FI76927C (fi) 1989-01-10
DE3100191C2 (et) 1988-09-01
GB2067072A (en) 1981-07-22
NO156153C (no) 1987-08-05
FI810056L (fi) 1981-07-12
NL8100037A (nl) 1981-08-03
ES8205353A1 (es) 1982-06-01
IN151913B (et) 1983-09-03
SE447450B (sv) 1986-11-17
AU6597681A (en) 1981-07-16

Similar Documents

Publication Publication Date Title
EP0287488B1 (fr) Médicament, produit diététique et produit d'hygiène sous la forme d'une composition pulvérulente obtenue par adsorption de principes actifs sur un sucre à dissolution rapide et procédé d'obtention de ladite composition
CH646604A5 (fr) Composition pharmaceutique a effet prolonge et son procede de fabrication.
US4308251A (en) Controlled release formulations of orally-active medicaments
CA2825053C (fr) Granules effervescents d'acide gamma-hydroxybutyrique
WO2010055260A1 (fr) Nouvelle composition à base d'acide gamma-hydroxybutyrique
FR2602423A1 (fr) Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
WO1982001649A1 (fr) Nouvelle forme galenique du fenofibrate, son procede d'obtention, son application comme medicament
JPH0122245B2 (et)
JP2003055203A (ja) ユビキノン含有製剤
CH647676A5 (fr) Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation.
JPS63107917A (ja) イブプロフエン徐放性製剤およびその製造方法
MX2007016072A (es) Formulaciones de diclofenac y metodos para usarlas.
FR2490493A1 (fr) Composition pharmaceutique ou alimentaire contenant de l'a -cetoglutarate de pyridoxine, procede pour sa preparation
FR2541287A1 (fr) Preparation stable administrable par voie orale de macrolides antibiotiques et procede pour les stabiliser
FR2524314A1 (fr) Medicament a action salidiuretique, contenant des dihydropyridines
JP2004507479A (ja) 粒状化可能な混合物の調製方法及びカルニチン・マグネシウム・ヒドロキシクエン酸塩
FR2529784A1 (fr) Medicament a liberation retardee contenant du 1-(p-(isopropylthio)-phenyl)-2-octylamino-1-propanol
AU2003235700B2 (en) Stable salts of o-acetylsalicylic acid containing basic amino acids II
EP0483320B1 (fr) Compositions pharmaceutiques du type a liberation prolongee destinees a l'administration par voie orale et leur procede de preparation
JPH02206A (ja) エキシホンと水溶性高分子化合物とを含有することを特徴とする新規製剤
JPH11322584A (ja) ベザフィブラート徐放性製剤
EP0412877A1 (fr) Nouvelle forme galénique orale améliorant la biodisponibilité
RU2233155C1 (ru) Способ получения витаминного комплекса в виде драже
CA2182024C (fr) Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
RU2155032C1 (ru) Способ получения лекарственной формы противовоспалительного симптоматического действия

Legal Events

Date Code Title Description
PL Patent ceased